NEW YORK and BERLIN, March 01, 2023(NASDAQ: ATAI) ("atai"), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, will participate in the Cowen 43rd Annual
NEW YORK and BERLIN, March 01, 2023 atai Life Sciences , a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, will participate in the. | March 1, 2023